Page last updated: 2024-10-21

3-methylcholanthrene and Tuberculosis, Drug-Resistant

3-methylcholanthrene has been researched along with Tuberculosis, Drug-Resistant in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stec, J1
Onajole, OK1
Lun, S1
Guo, H1
Merenbloom, B1
Vistoli, G1
Bishai, WR1
Kozikowski, AP1

Other Studies

1 other study available for 3-methylcholanthrene and Tuberculosis, Drug-Resistant

ArticleYear
Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection.
    Journal of medicinal chemistry, 2016, 07-14, Volume: 59, Issue:13

    Topics: Animals; Antitubercular Agents; Bacterial Proteins; Disease Models, Animal; Drug Design; Female; Hum

2016